China Bevacizumab Biosimilar Market Research Report Forecast 2017 to 2022

November 2017 | 110 pages | ID: CD47269E594EN
S&P Consulting

Abstracts

Delivery of the Report will take 2-3 working days once order is placed.

The China Bevacizumab Biosimilar Market Research Report Forecast 2017-2022 is a valuable source of insightful data for business strategists. It provides the Bevacizumab Biosimilar industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Bevacizumab Biosimilar market study provides comprehensive data which enhances the understanding, scope and application of this report.

This report provides comprehensive analysis of

• Key market segments and sub-segments
• Evolving market trends and dynamics
• Changing supply and demand scenarios
• Quantifying market opportunities through market sizing and market forecasting
• Tracking current trends/opportunities/challenges
• Competitive insights
• Opportunity mapping in terms of technological breakthroughs

The Major players reported in the market include:
Pfizer
Allergan
Alnylam Pharmaceuticals
Amgen
Angstrom Pharmaceuticals
Acceleron Pharma
Biocon
Bionomics
CASI Pharmaceuticals

China Bevacizumab Biosimilar Market: Product Segment Analysis
Type 1
Type 2
Type 3

China Bevacizumab Biosimilar Market: Application Segment Analysis
Application 1
Application 2
Application 3

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

Contents

CHAPTER 1 BEVACIZUMAB BIOSIMILAR MARKET OVERVIEW

1.1 Product Overview and Scope of Bevacizumab Biosimilar
1.2 Bevacizumab Biosimilar Market Segmentation by Type
  1.2.1 China Production Market Share of Bevacizumab Biosimilar by Type in 2016
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Bevacizumab Biosimilar Market Segmentation by Application
  1.3.1 Bevacizumab Biosimilar Consumption Market Share by Application in 2016
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 China Market Size Sales (Value) and Revenue (Volume) of Bevacizumab Biosimilar (2012-2021)

CHAPTER 2 CHINA ECONOMIC IMPACT ON BEVACIZUMAB BIOSIMILAR INDUSTRY

2.1 China Macroeconomic Environment Analysis
  2.1.1 China Macroeconomic Analysis
  2.1.2 China Macroeconomic Environment Development Trend
2.2 Effects to Bevacizumab Biosimilar Industry

CHAPTER 3 CHINA BEVACIZUMAB BIOSIMILAR MARKET COMPETITION BY MANUFACTURERS

3.1 China Bevacizumab Biosimilar Production and Share by Manufacturers (2015 and 2016)
3.2 China Bevacizumab Biosimilar Revenue and Share by Manufacturers (2015 and 2016)
3.3 China Bevacizumab Biosimilar Average Price by Manufacturers (2015 and 2016)
3.4 Manufacturers Bevacizumab Biosimilar Manufacturing Base Distribution, Production Area and Product Type
3.5 Bevacizumab Biosimilar Market Competitive Situation and Trends
  3.5.1 Bevacizumab Biosimilar Market Concentration Rate
  3.5.2 Bevacizumab Biosimilar Market Share of Top 3 and Top 5 Manufacturers
  3.5.3 Mergers & Acquisitions, Expansion

CHAPTER 4 CHINA BEVACIZUMAB BIOSIMILAR CAPACITY, PRODUCTION, REVENUE, CONSUMPTION, EXPORT AND IMPORT (2012-2017)

4.1 China Bevacizumab Biosimilar Capacity, Production and Growth (2012-2017)
4.2 China Bevacizumab Biosimilar Revenue and Growth (2012-2017)
4.3 China Bevacizumab Biosimilar Production, Consumption, Export and Import (2012-2017)

CHAPTER 5 CHINA BEVACIZUMAB BIOSIMILAR PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 China Bevacizumab Biosimilar Production and Market Share by Type (2012-2017)
5.2 China Bevacizumab Biosimilar Revenue and Market Share by Type (2012-2017)
5.3 China Bevacizumab Biosimilar Price by Type (2012-2017)
5.4 China Bevacizumab Biosimilar Production Growth by Type (2012-2017)

CHAPTER 6 CHINA BEVACIZUMAB BIOSIMILAR MARKET ANALYSIS BY APPLICATION

6.1 China Bevacizumab Biosimilar Consumption and Market Share by Application (2012-2017)
6.2 China Bevacizumab Biosimilar Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Applications
  6.3.2 Emerging Markets/Countries

CHAPTER 7 CHINA BEVACIZUMAB BIOSIMILAR MANUFACTURERS ANALYSIS

7.1 Pfizer
  7.1.1 Company Basic Information, Manufacturing Base and Competitors
  7.1.2 Product Type, Application and Specification
  7.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.1.4 Business Overview
7.2 Allergan
  7.2.1 Company Basic Information, Manufacturing Base and Competitors
  7.2.2 Product Type, Application and Specification
  7.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.2.4 Business Overview
7.3 Alnylam Pharmaceuticals
  7.3.1 Company Basic Information, Manufacturing Base and Competitors
  7.3.2 Product Type, Application and Specification
  7.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.3.4 Business Overview
7.4 Amgen
  7.4.1 Company Basic Information, Manufacturing Base and Competitors
  7.4.2 Product Type, Application and Specification
  7.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.4.4 Business Overview
7.5 Angstrom Pharmaceuticals
  7.5.1 Company Basic Information, Manufacturing Base and Competitors
  7.5.2 Product Type, Application and Specification
  7.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.5.4 Business Overview
7.6 Acceleron Pharma
  7.6.1 Company Basic Information, Manufacturing Base and Competitors
  7.6.2 Product Type, Application and Specification
  7.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.6.4 Business Overview
7.7 Biocon
  7.7.1 Company Basic Information, Manufacturing Base and Competitors
  7.7.2 Product Type, Application and Specification
  7.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.7.4 Business Overview
7.8 Bionomics
  7.8.1 Company Basic Information, Manufacturing Base and Competitors
  7.8.2 Product Type, Application and Specification
  7.8.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.8.4 Business Overview
7.9 CASI Pharmaceuticals
  7.9.1 Company Basic Information, Manufacturing Base and Competitors
  7.9.2 Product Type, Application and Specification
  7.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.9.4 Business Overview

CHAPTER 8 BEVACIZUMAB BIOSIMILAR MANUFACTURING COST ANALYSIS

8.1 Bevacizumab Biosimilar Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Bevacizumab Biosimilar

CHAPTER 9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Bevacizumab Biosimilar Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Bevacizumab Biosimilar Major Manufacturers in 2016
9.4 Downstream Buyers

CHAPTER 10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

CHAPTER 11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

CHAPTER 12 CHINA BEVACIZUMAB BIOSIMILAR MARKET FORECAST (2017-2022)

12.1 China Bevacizumab Biosimilar Production, Revenue Forecast (2017-2022)
12.2 China Bevacizumab Biosimilar Production, Consumption Forecast by Regions (2017-2022)
12.3 China Bevacizumab Biosimilar Production Forecast by Type (2017-2022)
12.4 China Bevacizumab Biosimilar Consumption Forecast by Application (2017-2022)
12.5 Bevacizumab Biosimilar Price Forecast (2017-2022)

CHAPTER 13 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Bevacizumab Biosimilar
Figure China Production Market Share of Bevacizumab Biosimilar by Type in 2016
Table Bevacizumab Biosimilar Consumption Market Share by Application in 2016
Figure China Bevacizumab Biosimilar Revenue (Million USD) and Growth Rate (2012-2021)
Table China Bevacizumab Biosimilar Capacity of Key Manufacturers (2015 and 2016)
Table China Bevacizumab Biosimilar Capacity Market Share of Key Manufacturers (2015 and 2016)
Figure China Bevacizumab Biosimilar Capacity of Key Manufacturers in 2015
Figure China Bevacizumab Biosimilar Capacity of Key Manufacturers in 2016
Table China Bevacizumab Biosimilar Production of Key Manufacturers (2015 and 2016)
Table China Bevacizumab Biosimilar Production Share by Manufacturers (2015 and 2016)
Figure 2015 Bevacizumab Biosimilar Production Share by Manufacturers
Figure 2016 Bevacizumab Biosimilar Production Share by Manufacturers
Table China Bevacizumab Biosimilar Revenue (Million USD) by Manufacturers (2015 and 2016)
Table China Bevacizumab Biosimilar Revenue Share by Manufacturers (2015 and 2016)
Table 2015 China Bevacizumab Biosimilar Revenue Share by Manufacturers
Table 2016 China Bevacizumab Biosimilar Revenue Share by Manufacturers
Table China Market Bevacizumab Biosimilar Average Price of Key Manufacturers (2015 and 2016)
Figure China Market Bevacizumab Biosimilar Average Price of Key Manufacturers in 2016
Table Manufacturers Bevacizumab Biosimilar Manufacturing Base Distribution and Sales Area
Table Manufacturers Bevacizumab Biosimilar Product Type
Figure Bevacizumab Biosimilar Market Share of Top 3 Manufacturers
Figure Bevacizumab Biosimilar Market Share of Top 5 Manufacturers
Table Church & Dwight Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Church & Dwight Bevacizumab Biosimilar Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Church & Dwight Bevacizumab Biosimilar Market Share (2012-2017)
Table Pfizer Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Pfizer Bevacizumab Biosimilar Production, Revenue, Price and Gross Margin (2012-2017)
Table Pfizer Bevacizumab Biosimilar Market Share (2012-2017)
Table Allergan Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Allergan Bevacizumab Biosimilar Production, Revenue, Price and Gross Margin (2012-2017)
Table Allergan Bevacizumab Biosimilar Market Share (2012-2017)
Table Alnylam Pharmaceuticals Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Alnylam Pharmaceuticals Bevacizumab Biosimilar Production, Revenue, Price and Gross Margin (2012-2017)
Table Alnylam Pharmaceuticals Bevacizumab Biosimilar Market Share (2012-2017)
Table Amgen Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Amgen Bevacizumab Biosimilar Production, Revenue, Price and Gross Margin (2012-2017)
Table Amgen Bevacizumab Biosimilar Market Share (2012-2017)
Table Angstrom Pharmaceuticals Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Angstrom Pharmaceuticals Bevacizumab Biosimilar Production, Revenue, Price and Gross Margin (2012-2017)
Table Angstrom Pharmaceuticals Bevacizumab Biosimilar Market Share (2012-2017)
Table Acceleron Pharma Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Acceleron Pharma Bevacizumab Biosimilar Production, Revenue, Price and Gross Margin (2012-2017)
Table Acceleron Pharma Bevacizumab Biosimilar Market Share (2012-2017)
Table Biocon Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Biocon Bevacizumab Biosimilar Production, Revenue, Price and Gross Margin (2012-2017)
Table Biocon Bevacizumab Biosimilar Market Share (2012-2017)
Table Bionomics Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Bionomics Bevacizumab Biosimilar Production, Revenue, Price and Gross Margin (2012-2017)
Table Bionomics Bevacizumab Biosimilar Market Share (2012-2017)
Table CASI Pharmaceuticals Basic Information, Manufacturing Base, Production Area and Its Competitors
Table CASI Pharmaceuticals Bevacizumab Biosimilar Production, Revenue, Price and Gross Margin (2012-2017)
Table CASI Pharmaceuticals Bevacizumab Biosimilar Market Share (2012-2017)
Figure Production Revenue Share of Bevacizumab Biosimilar by Type (2012-2017)
Figure 2015 Revenue Market Share of Bevacizumab Biosimilar by Type
Table China Bevacizumab Biosimilar Price by Type (2012-2017)
Figure China Bevacizumab Biosimilar Production Growth by Type (2012-2017)
Table China Bevacizumab Biosimilar Consumption by Application (2012-2017)
Table China Bevacizumab Biosimilar Consumption Market Share by Application (2012-2017)
Figure China Bevacizumab Biosimilar Consumption Market Share by Application in 2016
Table China Bevacizumab Biosimilar Consumption Growth Rate by Application (2012-2017)
Figure China Bevacizumab Biosimilar Consumption Growth Rate by Application (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Bevacizumab Biosimilar
Figure Manufacturing Process Analysis of Bevacizumab Biosimilar
Figure Bevacizumab Biosimilar Industrial Chain Analysis
Table Raw Materials Sources of Bevacizumab Biosimilar Major Manufacturers in 2015
Table Major Buyers of Bevacizumab Biosimilar
Table Distributors/Traders List
Figure China Bevacizumab Biosimilar Capacity, Production and Growth Rate Forecast (2017-2022)
Figure China Bevacizumab Biosimilar Revenue and Growth Rate Forecast (2017-2022)
Table China Bevacizumab Biosimilar Production, Import, Export and Consumption Forecast (2017-2022)
Table China Bevacizumab Biosimilar Production Forecast by Type (2017-2022)
Table China Bevacizumab Biosimilar Consumption Forecast by Application (2017-2022)

COMPANIES MENTIONED

Pfizer
Allergan
Alnylam Pharmaceuticals
Amgen
Angstrom Pharmaceuticals
Acceleron Pharma
Biocon
Bionomics
CASI Pharmaceuticals
Celgene Corporation
Enzon Pharmaceuticals
Five Prime Therapeutics
Fujifilm Kyowa Kirin Biologics
Genentech
Genexine
Hetero Drugs
ImClone Systems
Intas Pharmaceuticals
Kyowa Hakko Kirin
Levolta Pharmaceuticals
Mabtech
Marsala Biotech
Neumedicines
Novartis
Oncobiologics
Onyx Pharmaceuticals